Catalyst
Slingshot members are tracking this event:
ADRO Gastrointestinal cancer treatment pLADD to be evaluated in Aduro phase 1 trial, which will begin in first half of 2017
- Source Link:
- https://seekingalpha.com/filing/3351398
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADRO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 27, 2017
Occurred Source:
http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2303145
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Gastrointestinal Cancer, Pladd, Phase 1
